Calamos Advisors’s Sanaby Health Acquisition Corp. I Unit SANBU Stock Holding History

Calamos Advisors’s Portfolio SANBU Stock Details SANBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-40,000	Closed	-$401K	–	1560
2022 Q2	$401K	Hold	40,000	–	–	﹤0.01%	1087
2022 Q1	$403K	Hold	40,000	–	–	﹤0.01%	1091
2021 Q4	$406K	Buy	+40,000	New	+$405K	﹤0.01%	1061

Other funds holding SANBU

SFM

Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Calamos Advisors's SANBU Position: Q3 2022 in Review

Calamos Advisors sold out of Sanaby Health Acquisition Corp. I Unit (SANBU) in Q3 2022, closing a stake of 40,000 shares — an estimated $401K sold.

Calamos Advisors first reported a position in SANBU in Q4 2021 and held it in 3 quarters. The position peaked at $406K in Q4 2021. 8 funds tracked by Wall St. Rank hold SANBU as of Q3 2022.

Calamos Advisors reported no remaining Sanaby Health Acquisition Corp. I Unit position as of Q3 2022 after selling out during the quarter.
Calamos Advisors sold 40,000 Sanaby Health Acquisition Corp. I Unit shares in Q3 2022, an estimated $401K.
Calamos Advisors first reported a position in Sanaby Health Acquisition Corp. I Unit in Q4 2021 and held it in 3 quarters.
Calamos Advisors's Sanaby Health Acquisition Corp. I Unit position peaked at $406K in Q4 2021.
8 funds tracked by Wall St. Rank held Sanaby Health Acquisition Corp. I Unit as of Q3 2022.

Based on Calamos Advisors's 13F filing for Q3 2022, filed 24 Oct 2022.